tiprankstipranks
Trending News
More News >
PPJ Healthcare Enterprises Inc (PPJE)
OTHER OTC:PPJE
US Market

PPJ Healthcare Enterprises (PPJE) Ratios

Compare
52 Followers

PPJ Healthcare Enterprises Ratios

PPJE's free cash flow for Q1 2025 was $0.26. For the 2025 fiscal year, PPJE's free cash flow was decreased by $ and operating cash flow was
lt;0.01. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
2.45 2.53 2.56 2.70 2.63
Quick Ratio
2.45 2.52 2.56 2.69 2.62
Cash Ratio
<0.01 <0.01 <0.01 0.06 0.11
Solvency Ratio
>-0.01 <0.01 0.03 0.06 0.06
Operating Cash Flow Ratio
-0.04 0.32 0.36 0.46 2.25
Short-Term Operating Cash Flow Coverage
-0.11 0.93 0.98 1.13 5.31
Net Current Asset Value
$ 11.23M$ 11.58M$ 11.00M$ 11.17M$ 10.00M
Leverage Ratios
Debt-to-Assets Ratio
0.13 0.13 0.14 0.14 0.15
Debt-to-Equity Ratio
0.11 0.21 0.22 0.22 0.24
Debt-to-Capital Ratio
0.10 0.17 0.18 0.18 0.19
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
0.82 1.60 1.59 1.54 1.56
Debt Service Coverage Ratio
-0.01 <0.01 0.03 0.14 0.06
Interest Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
2.94 284.02 1.57 1.26 0.67
Interest Debt Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Net Debt to EBITDA
-67.40 320.40 34.04 6.13 13.66
Profitability Margins
Gross Profit Margin
16.26%15.56%30.39%38.06%43.13%
EBIT Margin
-7.97%1.22%10.51%17.85%22.13%
EBITDA Margin
-7.97%1.22%10.51%46.76%22.13%
Operating Profit Margin
-7.97%1.22%10.51%17.85%22.13%
Pretax Profit Margin
-7.97%1.22%10.51%17.85%21.76%
Net Profit Margin
-7.97%1.22%10.51%17.85%21.76%
Continuous Operations Profit Margin
-7.97%1.22%10.51%17.85%21.76%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
100.00%100.00%100.00%100.00%98.31%
Return on Assets (ROA)
-0.19%0.04%0.39%0.75%0.82%
Return on Equity (ROE)
-0.21%0.06%0.62%1.16%1.28%
Return on Capital Employed (ROCE)
-0.31%0.06%0.62%1.16%1.31%
Return on Invested Capital (ROIC)
-0.26%0.05%0.51%0.95%1.06%
Return on Tangible Assets
-0.20%0.04%0.41%0.79%0.82%
Earnings Yield
-4.32%88.01%4.52%6.65%3.64%
Efficiency Ratios
Receivables Turnover
0.22 0.28 0.30 0.28 0.28
Payables Turnover
2.87 3.96 17.66 21.74 45.52
Inventory Turnover
238.88 138.76 55.61 14.92 7.92
Fixed Asset Turnover
32.59 43.54 39.79 14.66 14.45
Asset Turnover
0.02 0.03 0.04 0.04 0.04
Working Capital Turnover Ratio
0.04 0.06 0.06 0.07 0.08
Cash Conversion Cycle
1.52K 1.24K 1.21K 1.31K 1.34K
Days of Sales Outstanding
1.65K 1.33K 1.23K 1.31K 1.30K
Days of Inventory Outstanding
1.53 2.63 6.56 24.46 46.06
Days of Payables Outstanding
127.10 92.23 20.67 16.79 8.02
Operating Cycle
1.65K 1.33K 1.23K 1.33K 1.35K
Cash Flow Ratios
Operating Cash Flow Per Share
>-0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow Per Share
>-0.01 <0.01 <0.01 <0.01 <0.01
CapEx Per Share
<0.01 0.00 0.00 0.00 <0.01
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
-69.63K 0.00 0.00 0.00 3.46M
Capital Expenditure Coverage Ratio
-69.63K 0.00 0.00 0.00 3.46M
Operating Cash Flow Coverage Ratio
-0.11 0.93 0.98 1.13 5.31
Operating Cash Flow to Sales Ratio
-0.58 3.67 3.56 3.82 21.34
Free Cash Flow Yield
-31.28%26528.16%153.35%142.30%357.54%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-23.14 1.14 22.10 15.04 27.44
Price-to-Sales (P/S) Ratio
1.85 0.01 2.32 2.68 5.97
Price-to-Book (P/B) Ratio
0.04 <0.01 0.14 0.17 0.35
Price-to-Free Cash Flow (P/FCF) Ratio
-3.20 <0.01 0.65 0.70 0.28
Price-to-Operating Cash Flow Ratio
-3.20 <0.01 0.65 0.70 0.28
Price-to-Earnings Growth (PEG) Ratio
-0.23 0.00 0.00 0.00 0.00
Price-to-Fair Value
0.04 <0.01 0.14 0.17 0.35
Enterprise Value Multiple
-90.54 321.53 56.14 11.87 40.64
Enterprise Value
3.48M 2.60M 4.20M 4.39M 5.83M
EV to EBITDA
-90.54 321.53 56.14 11.87 40.64
EV to Sales
7.22 3.91 5.90 5.55 8.99
EV to Free Cash Flow
-12.51 1.07 1.66 1.45 0.42
EV to Operating Cash Flow
-12.51 1.07 1.66 1.45 0.42
Tangible Book Value Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Shareholders’ Equity Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.00 0.00 0.00
Revenue Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Net Income Per Share
>-0.01 <0.01 <0.01 <0.01 <0.01
Tax Burden
1.00 1.00 1.00 1.00 1.00
Interest Burden
1.00 1.00 1.00 1.00 0.98
Research & Development to Revenue
0.23 0.13 0.00 0.03 0.02
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
7.24 301.42 33.89 21.40 98.10
Currency in USD